drugset
drugset / Trial / NCT02674347

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

NCT02674347 ↗

Phase 1 Completed 21 enrolled Wockhardt Quintiles, Inc. · collab
RandomizedParallel-groupQuadruple-blindOther

Summary

Study to evaluate the safety and tolerability of multiple escalating doses of intravenous (IV) Zidebactam in healthy adult human subjects.

Timeline

Start
2016-02
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Zidebactam Small molecule 3 g Intravenous
Subject Zidebactam Small molecule 6 g Intravenous

Indications

No indication recorded.